InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（22 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
22
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Watson David O., Directeur Juridique. Officer active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 47 reports have been published. Split: 0 buy · 22 sells. Total volume traded: €3.4m. Activity tracked since 28 May 2021. The latest transaction was filed on 28 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Watson David O.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报47 总计
144,517 股Common StockSEC:0001193125-26-224583:0
55,986 股0Common StockSEC:0001492422-26-000072:0
7,832 股@ US$21.76544.7% 占其流量Common StockSEC:0001492422-26-000054:0
2,475 股@ US$19.79291.4% 占其流量Common StockSEC:0001492422-26-000038:0
5,780 股@ US$22.18723.5% 占其流量Common StockSEC:0001492422-26-000025:0
888 股@ US$14.950.4% 占其流量Common StockSEC:0001492422-26-000017:0
5,000 股@ US$24.493.7% 占其流量Common StockSEC:0001492422-25-000014:0
5,000 股@ US$20.064.2% 占其流量Common StockSEC:0001492422-25-000012:0
5,000 股@ US$25.224.0% 占其流量Common StockSEC:0001492422-25-000009:0
5,000 股@ US$24.344.0% 占其流量Common StockSEC:0001492422-25-000007:0
20,000 股@ US$26.1718.0% 占其流量Common StockSEC:0001193125-25-202168:0
5,000 股@ US$27.805.8% 占其流量Common StockSEC:0001127602-25-020714:0
5,000 股@ US$19.5511.2% 占其流量Common StockSEC:0001127602-25-019411:0
5,000 股@ US$18.7712.2% 占其流量Common StockSEC:0001127602-25-017714:0
6,667 股0Common StockSEC:0000950170-25-034908:0
695 股@ US$29.52361.0% 占其流量Common StockSEC:0001127602-25-002389:0
3,323 股@ US$30.42554.8% 占其流量Common StockSEC:0001127602-25-001847:0
2,201 股@ US$29.95823.1% 占其流量Common StockSEC:0001127602-25-001631:0
42,762 股0Common StockSEC:0001127602-25-001631:1
4,965 股@ US$28.70216.8% 占其流量Common StockSEC:0001127602-25-001204:0
5,000 股@ US$34.2358.0% 占其流量Common StockSEC:0000950170-24-136202:0
10,569 股0Common StockSEC:0000950170-24-110373:0
3,762 股@ US$13.852.4% 占其流量Common StockSEC:0001127602-24-009113:0
781 股@ US$67.76692.4% 占其流量Common StockSEC:0001127602-24-004737:0
906 股@ US$64.13822.6% 占其流量Common StockSEC:0001127602-24-002755:0
47 条申报中的 25 条
About Watson David O.
Watson David O. is Directeur Juridique and General Counsel at Apellis Pharmaceuticals, Inc. He has filed 47 forms, all in the tracked sample, with 0 EUR of buys and 3,439,614 EUR of sells, and the dominant transaction nature is Cession. The tracked recent filings run from 2021-06-01 to 2026-05-14.
